Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...

Pancreatic cancer also has the lowest survival rates of all common cancers ... the 'lucky' 1 in 10 who are eligible for surgery, the recurrence rate of pancreatic cancer after surgical treatment ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

New research uncovers how distinct molecular profiles and immune signatures in metastatic pancreatic cancer impact survival and guide ... distinguish liver and lung recurrence and outcomes in ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to ...

The 5-year relative survival rate is low at about 3%, and patients with advanced pancreatic cancer, who have a high recurrence rate, are now able to experience a new treatment method that selectively ...

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA who received Celebrex had significantly better rates versus placebo.

Correlation of tumoral collagen width with overall survival and tumoral collagen straightness with distant recurrence-free survival in patients with pancreatic ductal adenocarcinoma. Analysis of ...

Despite surgical, genetic and molecular advances, its overall prognosis remains ... with advanced-stage pancreatic cancer, an approach with high rates of local recurrence. Stereotactic body ...

Strong median overall survival (OS) figures for various pancreatic cancer subgroups treated with ... a checkpoint inhibitor (pembrolizumab) for recurrent unresectable or metastatic head and ...